Literature DB >> 27717139

Vps35-dependent recycling of Trem2 regulates microglial function.

Jie Yin1,2, Xiaocui Liu3, Qing He1,2, Lujun Zhou1,2, Zengqiang Yuan1,4, Siqi Zhao1.   

Abstract

Triggering receptor expressed on myeloid cells 2 (Trem2), an immune-modulatory receptor, is preferentially expressed in microglia of central nervous system. Trem2 might be involved in the development of Alzheimer's disease (AD) through regulating the inflammatory responses and phagocytosis of microglia. However, the intracellular trafficking of Trem2 remains unclear. In this study, we showed that Trem2 in the plasma membrane underwent endocytosis and recycling. Trem2 is internalized in a clathrin-dependent manner and then recycled back to the plasma membrane through vacuolar protein sorting 35 (Vps35), the key component of cargo recognition core of retromer complex, but not Rab11. When Vps35 is knocked down, Trem2 accumulated in the lysosomes but was not degraded. More importantly, Vps35 deficiency leads to excessive lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) expression and IL-6 production, which can be abolished by Trem2 overexpression. Furthermore, R47H Trem2, an AD-associated mutant, failed to interact with Vps35 and became unstable compared with wild-type Trem2. Our study suggests that Vps35/retromer is responsible for recycling of Trem2 in the regulation of microglial function such as proinflammatory responses, whereas R47H mutation impairs Trem2 trafficking, which might contribute to AD.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; Trem2; Vps35; microglia; receptor recycling; retromer

Mesh:

Substances:

Year:  2016        PMID: 27717139     DOI: 10.1111/tra.12451

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  25 in total

Review 1.  Endosomal recycling reconciles the Alzheimer's disease paradox.

Authors:  Scott A Small; Gregory A Petsko
Journal:  Sci Transl Med       Date:  2020-12-02       Impact factor: 17.956

2.  Increased Microglial Activity, Impaired Adult Hippocampal Neurogenesis, and Depressive-like Behavior in Microglial VPS35-Depleted Mice.

Authors:  Joanna Ruth Appel; Shiyang Ye; Fulei Tang; Dong Sun; Hongsheng Zhang; Lin Mei; Wen-Cheng Xiong
Journal:  J Neurosci       Date:  2018-05-31       Impact factor: 6.167

Review 3.  Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

Authors:  Yuetiva Deming; Zeran Li; Bruno A Benitez; Carlos Cruchaga
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

Review 4.  Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders.

Authors:  Swarup Mitra; Avijit Banik; Sumit Saurabh; Malabika Maulik; Shailesh N Khatri
Journal:  J Neurosci       Date:  2022-01-13       Impact factor: 6.709

Review 5.  Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer's Disease.

Authors:  Scott A Small; Sabrina Simoes-Spassov; Richard Mayeux; Gregory A Petsko
Journal:  Trends Neurosci       Date:  2017-10       Impact factor: 13.837

Review 6.  Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.

Authors:  Jiqing Cao; Margaret B Zhong; Carlos A Toro; Larry Zhang; Dongming Cai
Journal:  Neurosci Lett       Date:  2019-03-16       Impact factor: 3.046

7.  Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans.

Authors:  Sabrina Simoes; Jessica L Neufeld; Gallen Triana-Baltzer; Setareh Moughadam; Emily I Chen; Milankumar Kothiya; Yasir H Qureshi; Vivek Patel; Lawrence S Honig; Hartmuth Kolb; Scott A Small
Journal:  Sci Transl Med       Date:  2020-11-25       Impact factor: 17.956

Review 8.  Microglial TREM2 in amyotrophic lateral sclerosis.

Authors:  Manling Xie; Shunyi Zhao; Dale B Bosco; Aivi Nguyen; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2021-12-18       Impact factor: 3.964

9.  LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease.

Authors:  Bradlee L Heckmann; Brett J W Teubner; Bart Tummers; Emilio Boada-Romero; Lacie Harris; Mao Yang; Clifford S Guy; Stanislav S Zakharenko; Douglas R Green
Journal:  Cell       Date:  2019-06-27       Impact factor: 66.850

Review 10.  Retromer dysfunction at the nexus of tauopathies.

Authors:  Sharad Kumar; Timothy J Sargeant; Julian M Carosi; Donna Denton
Journal:  Cell Death Differ       Date:  2021-01-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.